---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-229437"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2021-07-30T23:59:59+00:00"
generated_at: "2026-06-30T00:30:59.433496+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Candel appoints Diem Nguyen to board; adopts amended charter and bylaws upon IPO

## Summary
- Diem Nguyen appointed to newly created board vacancy, effective July 26, 2021, as Class III director.
- Nguyen is independent and will receive standard non-employee director compensation.
- Restated certificate authorizes 150M shares of common stock and 10M shares of undesignated preferred.
- Amended bylaws eliminate stockholder action by written consent and set procedures for proposals and nominations.

## SEC filing metadata
- accession: 0001193125-21-229437
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2021-07-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/0001193125-21-229437-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/d203496d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-229437
- JSON: https://secwatch.observer/filing/0001193125-21-229437.json
- Plain text: https://secwatch.observer/filing/0001193125-21-229437.txt

## Key facts
- Executive change
  Diem Nguyen was appointed as Director at Candel Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 12, 2021, the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Diem Nguyen, Ph.D. to fill a newly created vacancy on the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/0001193125-21-229437-index.htm
- Executive change
  Carrie Cox resigned as Director at Candel Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: resulting from the resignation of Carrie Cox from the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312521229437/0001193125-21-229437-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.